Brief: TRACON Pharmaceuticals Q3 Net Income USD 10.763 Million
09/11/2023 21:02
Nov 09 (Reuters) - TRACON Pharmaceuticals Q3 operating expenses USD 1.588 million. * Q3 income from operations USD -1.588 million * Q3 basic EPS USD 0.29
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants